Quick-Push antibody therapy could make life easier for Immune-Weak patients
NCT ID NCT04354129
First seen May 10, 2026 · Last updated May 13, 2026 · Updated 1 time
Summary
This study looks at whether giving Cutaquig® (a medicine that helps fight infections) through a faster, manual push method is safe and comfortable for adults with primary or secondary immune deficiencies. About 36 participants will try this method at home. The goal is to see if the faster approach is just as safe and more convenient than standard infusions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNE DEFICIENCY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alberta
Edmonton, Alberta, T6G 2R3, Canada
Conditions
Explore the condition pages connected to this study.